GS-9191

DB15084InvestigationalSmall molecule

GS-9191 is under investigation in clinical trial NCT00499967 (Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts).

Formula / weight: C₃₇H₅₁N₈O₆P · 734.839 g/mol (avg)
Code names: GS-9191

Resolves to

Compound

UNII5I2GJW5Z2QCAS859209-84-0ChEMBLCHEMBL1652465

Structure

InChIKeyYTMOQFAFGKLYIW-CONSDPRKSA-NSMILESCC(C)COC(=O)[C@H](CC1=CC=CC=C1)NP(=O)(COCCN1C=NC2=C1N=C(N)N=C2NC1CC1)N[C@@H](CC1=CC=CC=C1)C(=O)OCC(C)C

Transporters

P08183ABCB1Q4U2R8SLC22A6Q9UNQ0ABCG2

What you can answer from here — as of July 08, 2026

3TransportersSubstrate / inhibitor direction, not just membership

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of GS-9191, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account